MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1382.27%
Quick Ratio
1382.27%
Cash Ratio
557.63%
Debt to Asset Ratio
11.06%
Unit: Thousand (K) dollars
Assets Breakdown
    • Available-for-sale securities
    • Cash and cash equivalents
    • Operating lease, right-of-use as...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
159,394
59,900
61,364
138,933
Available-for-sale securities
218,284
127,950
174,778
129,177
Prepaid expenses and other current assets
16,792
16,384
8,710
10,530
Restricted cash, current
638
1,222
-
-
Total current assets
395,108
205,456
244,852
278,640
Operating lease, right-of-use assets
20,667
21,924
22,535
23,133
Property and equipment, gross
-
18,359
-
-
Less accumulated depreciation and amortization
-
14,190
-
-
Property and equipment, net
3,959
4,169
4,356
4,317
Other non-current assets
138
223
247
278
Restricted cash, net of current portion
708
768
1,924
1,924
Total non-current assets
25,472
27,084
29,062
29,652
Total assets
420,580
232,540
273,914
308,292
Accounts payable
4,360
3,224
8,429
4,704
Accrued expenses and other current liabilities
17,790
18,945
19,050
16,546
Operating lease liabilities, current
2,234
2,103
2,032
1,943
Finance lease liabilities
-
0
281
953
Derivative liabilities
4,200
9,200
6,550
5,700
Total current liabilities
28,584
33,472
36,342
29,846
Operating lease liabilities, net of current portion
17,921
19,058
19,624
20,155
Total non-current liabilities
17,921
19,058
19,624
20,155
Total liabilities
46,505
52,530
55,966
50,001
Common stock, 0.001 par value 480,000,000 and 240,000,000 shares authorized at june 30, 2026 and december 31, 2025 105,125,366 and 78,967,888 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
105
79
78
78
Additional paid-in capital
1,443,394
1,137,654
1,125,810
1,120,463
Accumulated other comprehensive income
-113
52
48
-38
Accumulated deficit
-1,069,311
-957,775
-907,988
-862,212
Total stockholders equity
374,075
180,010
217,948
258,291
Total liabilities and stockholders equity
420,580
232,540
273,914
308,292
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Available-for-sale securities$218,284K (68.98%↑ Y/Y)Cash and cashequivalents$159,394K (14.73%↑ Y/Y)Prepaid expenses andother current assets$16,792K (59.47%↑ Y/Y)Restricted cash, current$638K Operating lease,right-of-use assets$20,667K (-10.66%↓ Y/Y)Property and equipment,net$3,959K (-8.29%↓ Y/Y)Restricted cash, net ofcurrent portion$708K (-63.20%↓ Y/Y)Other non-currentassets$138K (-50.36%↓ Y/Y)Total current assets$395,108K (41.80%↑ Y/Y)Total non-currentassets$25,472K (-14.10%↓ Y/Y)Total assets$420,580K (36.42%↑ Y/Y)Total liabilities andstockholders equity$420,580K (36.42%↑ Y/Y)Total stockholdersequity$374,075K (44.83%↑ Y/Y)Total liabilities$46,505K (-6.99%↓ Y/Y)Accumulated deficit-$1,069,311K (-24.02%↓ Y/Y)Accumulated othercomprehensive income-$113K (-197.37%↓ Y/Y)Additional paid-in capital$1,443,394K (28.82%↑ Y/Y)Total currentliabilities$28,584K (-4.23%↓ Y/Y)Total non-currentliabilities$17,921K (-11.08%↓ Y/Y)Common stock, 0.001 parvalue 480,000,000 and...$105K (34.62%↑ Y/Y)Accrued expenses andother current...$17,790K (7.52%↑ Y/Y)Accounts payable$4,360K (-7.31%↓ Y/Y)Derivative liabilities$4,200K (-26.32%↓ Y/Y)Operating leaseliabilities, current$2,234K (14.98%↑ Y/Y)Operating leaseliabilities, net of current...$17,921K (-11.08%↓ Y/Y)

Solid Biosciences Inc. (SLDB)

Solid Biosciences Inc. (SLDB)